Symbol="BTAI"
AssetType="Common Stock"
Name="BioXcel Therapeutics Inc"
Description="BioXcel Therapeutics, Inc., a clinical-phase biopharmaceutical company, focuses on the development of artificial intelligence-based drugs in the fields of neuroscience and immuno-oncology in the United States. The company is headquartered in New Haven, Connecticut."
CIK="1720893"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="555 LONG WHARF DRIVE, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="229778000"
EBITDA="-179032992"
PERatio="None"
PEGRatio="None"
BookValue="1.821"
DividendPerShare="0"
DividendYield="0"
EPS="-6.12"
RevenuePerShareTTM="0.021"
ProfitMargin="0"
OperatingMarginTTM="-308.71"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-1.515"
RevenueTTM="581000"
GrossProfitTTM="355000"
DilutedEPSTTM="-6.12"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="47.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4131.89"
PriceToBookRatio="3.966"
EVToRevenue="2657.94"
EVToEBITDA="-2.748"
Beta="0.84"
num_52WeekHigh="34.12"
num_52WeekLow="5.88"
num_50DayMovingAverage="15.23"
num_200DayMovingAverage="20.1"
SharesOutstanding="29159600"
DividendDate="None"
ExDividendDate="None"
symbol="BTAI"
open="7.78"
high="7.99"
low="7.61"
price="7.72"
volume="830561.00"
latest_trading_day="2023-08-03"
previous_close="7.88"
change="-0.16"
change_percent="-2.0305%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="78"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="22"
Volume_recent_avg="1889944"
Change_recent_avg="-0.04"
Delta_recent_avg="1.45"
Variance_recent_avg="0.73"
Change_ratio_recent_avg="-0.58"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="22"
Aroon_momentum_negative="78"
image_negative_thumbnail_id_1="169"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_negative_thumbnail_id_2="132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="982"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
